FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

23771000087108: COMVAX 7.5 micrograms and 5 micrograms per 0.5 milliliter suspension for injection Merck & Co. Inc. (real clinical drug)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2018. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
109081000087111 Hib-HB COMVAX MCI en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
109091000087113 COMVAX 7.5 micrograms and 5 micrograms per 0.5 milliliter suspension for injection Merck & Co. Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
109241000087112 Hib-HB COMVAX MCI fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)
137701000087117 COMVAX 7.5 micrograms and 5 micrograms per 0.5 milliliter suspension for injection Merck & Co. Inc. (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hib-HB COMVAX MCI a pour principe actif (attribut) Hepatitis B virus recombinant surface antigen true Inferred relationship Some 2
Hib-HB COMVAX MCI est un(e) (attribut) Hib-HB Haemophilus influenzae de type b + hépatite B pédiatrique non spécifié true Inferred relationship Some
Hib-HB COMVAX MCI Has supplier Merck & Co. Inc. (supplier) true Inferred relationship Some
Hib-HB COMVAX MCI est un(e) (attribut) Product manufactured as parenteral dose form (product) true Inferred relationship Some
Hib-HB COMVAX MCI a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
Hib-HB COMVAX MCI a pour principe actif (attribut) Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Neisseria meningitidis serogroup B outer membrane protein (substance) true Inferred relationship Some 1
Hib-HB COMVAX MCI Count of base of active ingredient deux false Inferred relationship Some
Hib-HB COMVAX MCI Plays role Active immunity stimulant role (role) true Inferred relationship Some
Hib-HB COMVAX MCI a pour principe actif (attribut) Hepatitis B virus recombinant vaccine (substance) false Inferred relationship Some 1
Hib-HB COMVAX MCI est un(e) (attribut) Hib-HB Haemophilus influenzae de type B + hépatite B pédiatrique non spécifié false Inferred relationship Some
Hib-HB COMVAX MCI a pour principe actif (attribut) Haemophilus influenzae type b vaccine (substance) false Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Administered tradename codes for vaccines reference set (foundation metadata concept)

Back to Start